For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

GlaxoSmithKline To Sell 5.69% Stake In Hindustan Unilever

By Staff
|

British multinational pharmaceutical company GlaxoSmithKline Plc will be selling 5.69 percent stake in Hindustan Unilever (HUL) via block deals at a price band of Rs 1,850-1,950 per share. The company said on Wednesday that this deal will be valued around $3.2-3.4 billion.

GlaxoSmithKline To Sell 5.69% Stake In Hindustan Unilever
Hindustan Unilever: Quotes, News
BSE 2007.55BSE Quote24.65 (-1.23%)
NSE 2009.85NSE Quote22.25 (-1.11%)
 

Morgan Stanley, HSBC and JPMorgan will be the advisors to the deal.

The price band of the deal is at a discount of 3-8 percent to the closing price of HUL of Rs 2,010.2 per share on Wednesday.

HUL's deal to buy GSK's Horlicks nutrition business for $3.8 billion for a consideration in cash and shares of HUL was completed in April 2020.

Story first published: Wednesday, May 6, 2020, 17:38 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more